The collective findings suggest that KNSTRN exhibits high expression levels across various cancer types, including breast cancer, thereby indicating its potential as a pathological biomarker for the accurate diagnosis of breast cancer. The gene discussed is KNSTRN; the disease is breast carcinoma.